ARGX•benzinga•
With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around?
Summary
HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 27, 2025 by benzinga